Hongming Liu

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

Shukui Qin, Minshan Chen, Ann‐Lii Cheng et al. · The Lancet · 2023 · 415 citations · Full text

Surgical Oncology, Hepatology, Medicine +8

ABi₂(IO₃)₂F₅ (A=K, Rb, and Cs): A Combination of Halide and Oxide Anionic Units To Create a Large Second‐Harmonic Generation Response with a Wide Bandgap

Hongming Liu, Qi Wu, Xingxing Jiang et al. · Angewandte Chemie International Edition · 2017 · 138 citations

RbIO₃ and RbIO₂F₂: Two Promising Nonlinear Optical Materials in Mid-IR Region and Influence of Partially Replacing Oxygen with Fluorine for Improving Laser Damage Threshold

Qi Wu, Hongming Liu, Fangchao Jiang et al. · Chemistry of Materials · 2016 · 123 citations

Optical Materials, Laser Damage Threshold, Engineering +18

Physiological β-amyloid clearance by the liver and its therapeutic potential for Alzheimer’s disease

Yuan Cheng, Chen-Yang He, Ding‐Yuan Tian et al. · Acta Neuropathologica · 2023 · 86 citations

Neurodegenerative Diseases, Therapeutic Potential, Alzheimer's Disease +11

LINC01140 promotes the progression and tumor immune escape in lung cancer by sponging multiple microRNAs

Rongmu Xia, Guojun Geng, Xiuyi Yu et al. · Journal for ImmunoTherapy of Cancer · 2021 · 67 citations · Full text

Immunology, Cancer Biology, Tumor Biology +17